Clinical and Immunological Follow-Up of Pemphigus Patients on Adjuvant Treatment with Immunoadsorption or Rituximab

Publisher： Karger

E-ISSN： 1421-9832|218|3|237-245

ISSN： 1018-8665

Source： Dermatology, Vol.218, Iss.3, 2008-12, pp. : 237-245

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rituximab in Childhood Pemphigus Vulgaris: A Long-Term Follow-Up Case and Review of the Literature

By  

Dermatology, Vol. 221, Iss. 1, 2010-04 ,pp. : 13-16

Karger

Access to resources Recommend Favorite

The Value of Anti-Desmoglein Enzyme-Linked Immunosorbent Assay in the Immunological Follow-Up of Pemphigus

By  

Dermatology, Vol. 229, Iss. 3, 2014-09 ,pp. : 256-262

Karger

Access to resources Recommend Favorite

Prolonged Clinical Remission of Patients with Severe Pemphigus upon Rapid Removal of Desmoglein-Reactive Autoantibodies by Immunoadsorption

By  

Dermatology, Vol. 212, Iss. 2, 2006-03 ,pp. : 177-187

Karger

Access to resources Recommend Favorite

Adjuvant Treatment of Recalcitrant Bullous Pemphigoid with Immunoadsorption

By  

Dermatology, Vol. 224, Iss. 3, 2012-06 ,pp. : 224-227

Karger

Access to resources Recommend Favorite

Pilot Study of 19 Patients with Severe Pemphigus: Prophylactic Treatment with Rituximab Does Not Appear to be Beneficial

By  

Dermatology, Vol. 228, Iss. 2, 2014-02 ,pp. : 158-165

Karger

Access to resources Recommend Favorite